Navigation Links
Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
Date:10/6/2008

Vice President and Chief Medical Officer at Ironwood.

"These novel findings provide valuable insight into the possible role of cGMP in alleviating intestinal pain and may explain the reduction in intestinal pain observed in patients with IBS-C treated with linaclotide in our Phase 2b studies," said Mark Currie, Ph.D., Senior Vice President, R&D and Chief Scientific Officer at Ironwood.

About Linaclotide

Linaclotide is a first-in-class compound currently being evaluated for the treatment of IBS-C, chronic constipation (CC), and other gastrointestinal disorders. Linaclotide was designed to exert its effect on the intestine with minimal systemic exposure. Linaclotide is an agonist of guanylate cyclase type-C, a receptor found on the lining of the intestine. Linaclotide demonstrated proof of concept in a comprehensive Phase 2b program, comprised of two clinical studies in over 700 patients with either IBS-C or CC. In patients with IBS-C, linaclotide reduced abdominal pain and relieved constipation-the hallmarks of the condition-throughout the 12-week treatment period. In patients with CC, linaclotide reduced constipation throughout the 4-week study period. Linaclotide was well tolerated at all doses in both Phase 2b studies, with the most common adverse event being diarrhea. A United States patent covering linaclotide composition of matter expires in 2025. In September 2007, Ironwood and Forest Laboratories entered into a 50/50 collaboration to co-develop and co-promote linaclotide in the United States. Ironwood retains exclusive rights to linaclotide outside of North America.

About Irritable Bowel Syndrome (IBS)

One out of six adults in developed countries suffers from IBS, a chronic condition marked by abdominal pain and disturbed bowel function. IBS accounts for 12% of adult visits to primary care physicians and is the most common disorder diagnosed by gastroenterologists. Healthcare costs associated with IBS exceed $25 billion ann
'/>"/>

SOURCE Ironwood Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
5. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... REDWOOD CITY, Calif. , May 22, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that interim chief executive officer ... 2015 Healthcare Conference and chief financial officer Tim ... Science Conference. Details of the two presentations are as ...
(Date:5/21/2015)... Research and Markets ( ... "North American Active Wound Care Market by ... & Ulcer), by End-User (In-Patient, & Out-Paient) - ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North ... grow at a CAGR of 3.1% from 2014 ...
(Date:5/21/2015)... , May 21, 2015  Cardica, Inc. (Nasdaq: ... employee Greg Watson , the company,s vice president of ... the company,s common stock, at a per share exercise price ... The stock option was granted pursuant to Cardica, Inc.,s Inducement ... in May 2015 under Rule 5653(c)(4) of the Nasdaq Global ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2
... Oct. 11 Halozyme Therapeutics, Inc. (Nasdaq: ... targeting the extracellular matrix , today announced a ... programs through key clinical inflection points in 2011 and ... such as validation of Halozyme,s commercial scale manufacturing process ...
... China-Biotics to Attend BNP Paribas China Conference -- SHANGHAI, Oct. 11 /PRNewswire-Asia-FirstCall/ -- ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
Cached Medicine Technology:Halozyme Therapeutics Announces Implementation of Development Focused Strategy 2Halozyme Therapeutics Announces Implementation of Development Focused Strategy 3Halozyme Therapeutics Announces Implementation of Development Focused Strategy 4China-Biotics to Attend BNP Paribas China Conference 2China-Biotics to Attend BNP Paribas China Conference 3China-Biotics to Attend BNP Paribas China Conference 4China-Biotics to Attend BNP Paribas China Conference 5China-Biotics to Attend BNP Paribas China Conference 6
(Date:5/22/2015)... Jupiter, FL (PRWEB) May 22, 2015 ... Ed Begley, Jr., scheduled to broadcast on Friday, May ... PST, via Discovery Channel. , In this episode Innovations ... companies get back to business quickly through disaster recovery ... NDPTC, a company that works collaboratively to develop and ...
(Date:5/22/2015)... May 22, 2015 Steven Winter Associates ... Zuluaga, has been selected by Consulting-Specifying Engineer (CSE) magazine ... winners are featured in the May/June issue of the ... industry professionals age 40 and younger who have, and ... as well as in other areas of their professional ...
(Date:5/22/2015)... 2015 A new program for the ... the field of Physical Therapy. , James Earl ... mystery out of physical therapy and discusses how the ... for a variety of ailments and injuries. Physical ... exercise plan that enhances daily activities such as house ...
(Date:5/22/2015)... 2015 In efforts to offer full ... containing particular muscles stretches has been a large focus ... stretches now complete, Chunk Fitness envisions a mid-June launch ... filmed and released at a later point in time. ... http://www.chunkfitness.com/stretches . , About the Company: Chunk Fitness ...
(Date:5/22/2015)... Viejo, CA (PRWEB) May 22, 2015 ... editable lower thirds designed exclusively for Final Cut Pro ... compatible with any design. , Intuitive on-screen-controls allow ... unique lower third. Reflections, colors, layouts, and much more ... Inspector window. , Pro3rd Impression comes ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2
... TUESDAY, May 17 (HealthDay News) -- A DNA region linked ... scientists. The studies by teams at Washington University School ... the United Kingdom pinpointed a region on chromosome 3 that ... analyzed data from 91 families in Australia and 25 families ...
... third-degree burns and other traumatic injuries endure pain, disfigurement, ... to grow back. Improved tissue grafts designed by Cornell ... healthy skin to invade the wounded area and reduce ... were engineered in the lab of Abraham Stroock, associate ...
... high-school students to surgeons, anyone who has pulled an all-nighter ... day: trouble focusing, a fuzzy memory and other cognitive impairments. ... the brain and the neurochemical basis for sleep deprivation,s effects ... in Penn,s School of Arts and Sciences and director of ...
... Reporter , TUESDAY, May 17 (HealthDay News) -- The ... and bones can also keep painful kidney stones at ... presenting data on Tuesday at the American Urological Association,s ... as diet, weight, calorie and calcium intake and medication ...
... By Maureen Salamon HealthDay Reporter , TUESDAY, ... harbor the human papillomavirus (HPV) responsible for cervical cancer ... means that boys as well as girls should get ... a small Austrian study, nearly a third of the ...
... at the University of Arizona College of Pharmacy found ... software systems the computer programs that are in ... correctly identified potentially dangerous drug-drug interactions. The study ... the research team tested the pharmacy software using a ...
Cached Medicine News:Health News:Gene Region Seems Linked to Depression 2Health News:Artificial tissue promotes skin growth in wounds 2Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 2Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 3Health News:What Protects the Heart May Also Ward Off Kidney Stones 2Health News:What Protects the Heart May Also Ward Off Kidney Stones 3Health News:Foreskin May Be Reservoir for HPV 2Health News:Foreskin May Be Reservoir for HPV 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: